[HTML][HTML] Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1
WY Lui, A Bharti, NHM Wong, S Jangra… - PLoS …, 2023 - journals.plos.org
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1.
WY Lui, A Bharti, NM Wong, S Jangra, MG Botelho… - Plos …, 2023 - europepmc.org
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
[HTML][HTML] Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1
WY Lui, A Bharti, NHM Wong, S Jangra… - PLOS …, 2023 - ncbi.nlm.nih.gov
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1
WY Lui, A Bharti, MG Botelho, KS Yuen - PLoS Pathogens, 2023 - search.proquest.com
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
[PDF][PDF] Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1
WY Lui, A Bharti, NHM Wong, S Jangra… - PLoS …, 2023 - pdfs.semanticscholar.org
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1
WY Lui, A Bharti, NHM Wong, S Jangra… - PLoS …, 2023 - pubmed.ncbi.nlm.nih.gov
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1.
WY Lui, A Bharti, NHM Wong, S Jangra… - PLoS …, 2023 - search.ebscohost.com
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
Suppression of cGAS-and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1.
WY Lui, A Bharti, NM Wong, S Jangra, MG Botelho… - Plos …, 2023 - europepmc.org
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …
responses. Here we reported on mitigation of type I interferon (IFN) production by EBV …